Henry D, Lopert R
Discipline of Clinical Pharmacology, Faculty of Medicine and Health Sciences, The University of Newcastle, Waratah, New South Wales, Australia.
Clin Ther. 1999 May;21(5):909-15. doi: 10.1016/s0149-2918(99)80012-5.
This paper provides an overview of the use of pharmacoeconomic analysis in the process that governs drug reimbursement decisions in Australia. It discusses the methods by which drugs are evaluated, both clinically and economically, and the means by which these 2 facets are amalgamated; the types of pharmacoeconomic data submitted in support of requests for reimbursement; the methods and standards used to assess these data; some of the more commonly encountered flaws in the data submitted; and how the different types of data influence reimbursement decisions.
本文概述了药物经济学分析在澳大利亚药品报销决策管理过程中的应用。它讨论了药物在临床和经济方面的评估方法，以及这两个方面相结合的方式；为支持报销申请而提交的药物经济学数据类型；用于评估这些数据的方法和标准；提交数据中一些较为常见的缺陷；以及不同类型的数据如何影响报销决策。
